Home / Resource Library / Challenges associated with the use of Bruton’s tyrosine kinase inhibitors: A life‑saving therapy for chronic lymphocytic leukemia
Challenges associated with the use of Bruton’s tyrosine kinase inhibitors: A life‑saving therapy for chronic lymphocytic leukemia